Data / Form D filings / Affinium Pharmaceuticals Ltd
Affinium Pharmaceuticals Ltd: Form D filings
Affinium Pharmaceuticals Ltd, a pharmaceuticals company in Toronto, Ontario, Canada, filed 3 Form D notices with the SEC between 2010 and 2013. The latest, on September 10, 2013, reports $18.9 million sold of a $18.9 million offering to 8 investors.
Find out what Affinium Pharmaceuticals Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 Front Street West, Suite 3004, Toronto, Ontario, Canada, M5V 3
- Phone
- (416) 645-6613
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1398436
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2013 | Amendment | $18,900,000 | $18,900,000 | $0 | 8 | Aug 19, 2011 | sec.gov |
| Aug 31, 2011 | New notice | $17,000,000 | $6,999,999 | $10,000,001 | 6 | Aug 19, 2011 | sec.gov |
| May 21, 2010 | Amendment | $22,000,000 | $18,000,000 | $4,000,000 | 8 | Mar 23, 2007 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Owen G. Roberts | Executive Officer | |
| Edward Mascioli | Executive Officer, Director | |
| Stuart J.M. Collinson | Director | |
| Damian J.M. Lamb | Director | |
| Hamish J.M. Cameron | Director | |
| Robert J.M. Radie | Director |
Every Form D from the week of Sep 9, 2013 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Affinium Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.